PAR-21-128 - The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 5

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute NOT-CA-23-035 NCI Jan 18, 2023 Nov 13, 2024 K22, K08, K99/R00, K01
Notice of Special Interest (NOSI): Adaptive Biomaterials for Cancer Biology NOT-CA-23-030 NCI Jan 10, 2023 May 7, 2025 R01, K22, K99/R00
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer NOT-CA-22-085 NCI May 5, 2022 Jul 5, 2027 K22, R01, K08, K01, R21, R03, K99/R00

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer NOT-CA-23-018 NCI Jan 19, 2023 Sep 8, 2024 K01, R01, K22, K08, R21, U34, K99/R00, P01, R34
Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy NOT-CA-22-063 NCI NIAID NIAMS NIDCR May 3, 2022 Jul 5, 2024 R01, R21, K99/R00, K01, K08, K22, R03, R15
For technical issues E-mail OER Webmaster